Stay updated on Nivolumab in Advanced Cutaneous Squamous Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Advanced Cutaneous Squamous Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Advanced Cutaneous Squamous Cell Carcinoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The record for a phase II study evaluating nivolumab in patients with advanced cutaneous squamous cell carcinoma is now available, including its treatment plan, eligibility criteria, study locations, and outcome measures.
    Difference
    40%
    Check dated 2026-11-08T05:21:53.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T02:27:21.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A sitewide notice was added announcing NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and linking to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T02:30:45.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T02:17:38.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T03:15:18.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error screen, replacing the usual study record content. Visible elements include the 403 header and standard footer, signaling restricted access and preventing interaction with the page.
    Difference
    17%
    Check dated 2026-09-20T01:21:29.000Z thumbnail image

Stay in the know with updates to Nivolumab in Advanced Cutaneous Squamous Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Advanced Cutaneous Squamous Cell Carcinoma Clinical Trial page.